The Drosophila tumor suppressor gene fat encodes a large cadherin that regulates growth and a form of tissue organization known as planar cell polarity (PCP). Fat regulates growth via the Hippo kinase pathway [1] [2] [3] [4] , which controls expression of genes promoting cell proliferation and inhibiting apoptosis (reviewed in [5] [6] [7] [8] [9] [10] [11] ). The Hippo pathway is highly conserved and is implicated in the regulation of mammalian growth and cancer development [12] [13] [14] [15] [16] [17] [18] . Genetic studies suggest that Fat activity is regulated by binding to another large cadherin, Dachsous (Ds) [19] [20] [21] [22] [23] [24] [25] . The tumor suppressor discs overgrown (dco)/Casein Kinase I d/3 also regulates Hippo activity and PCP [1, 26, 27] . The biochemical nature of how Fat, Ds, and Dco interact to regulate these pathways is poorly understood. Here we demonstrate that Fat is cleaved to generate 450 kDa and 110 kDa fragments (Fat 450 and Fat 110 ). Fat 110 contains the cytoplasmic and transmembrane domain. The cytoplasmic domain of Fat binds Dco and is phosphorylated by Dco at multiple sites. Importantly, we show Fat forms cis-dimers and that Fat phosphorylation is regulated by Dachsous and Dco in vivo. We propose that Ds regulates Dco-dependent phosphorylation of Fat and Fat-associated proteins to control Fat signaling in growth and PCP.
Results and Discussion
Fat Is Proteolytically Processed into 450 kDa and 110 kDa Fragments To characterize Fat, we generated antibodies against the cytoplasmic domain (a-Fat-IC) and analyzed larval extracts by western blotting. Because Fat is predicted to encode a protein of w560 kDa, we separated Drosophila imaginal disc extracts on 2.5% acrylamide gels supported with agarose to more clearly resolve large proteins. Western blotting demonstrated that a-Fat-IC was specific, as shown by the fact that the 560 kDa band expected for full-length Fat was present in wild-type extracts and absent from extracts of fat mutant larvae ( Figure 1A) . Surprisingly, this antibody also recognized a lower molecular weight band of w110 kDa that was absent in fat mutants, indicating that the 110 kDa band was derived from the fat locus. Northern analysis and screening of EST databases indicated that Fat is not alternatively spliced, suggesting that the 110 kDa protein may represent a cleavage product of Fat (data not shown).
To determine whether the 110 kDa form derives from fulllength Fat, we conducted in vivo pulse-chase experiments, taking advantage of the temperature dependence of the UAS-Gal4 system. At 18 C, there is little Gal4-dependent transcription. Flies expressing UAS-fat-HA were raised at 18 C and transferred to 37 C for 45 min to allow a pulse of transcription, then returned to 18 C, and samples were taken at regular intervals for western blotting ( Figure 1B) Figure 1B ). This suggests that Fat is synthesized as a 560 kDa form, which undergoes proteolytic processing, yielding Fat 110 and presumably an extracellular fragment of 450 kDa (Fat 450 ). We also detect a form of Fat at w70 kDa, but because of variability in detection ( Figure 1B ), we cannot exclude that this is a degradation product.
To detect the putative Fat 450 N-terminal proteolytic fragment, we analyzed larval extracts with antibodies against the extracellular domain of Fat (a-Fat-N). Consistent with predicted extracellular cleavage, this antibody recognized a protein of w450 kDa ( Figure 1C ). This antibody also weakly detected Fat 560 (data not shown). Together, these data suggest that Fat is synthesized as a transient 560 kDa precursor, which is cleaved into 450 kDa and 110 kDa fragments ( Figure 1D ).
To Figure S1A available online). We note that the endogenous 560 kDa band is not easily detected with a-Fat-IC when standard chemoluminescence reagents are used (data not shown). In contrast, the 110 kDa band is readily detectable. The 560 kDa band is thus probably transient, and endogenous Fat exists as 110 kDa and 450 kDa forms.
To determine whether this processing is conserved, we analyzed mouse ES cell and embryonic extract by using antibodies against the cytoplasmic domain of the vertebrate ortholog of Fat, Fat4 [28] . This antibody recognizes proteins of w540 kDa and w140 kDa, suggesting that processing of the Fat family of cadherins is conserved ( Figure S1B ). Significantly, an antibody against the extracellular domain of Fat4 recognizes both a w540 kDa band and a smaller N-terminal cleavage product of w400 kDa ( Figure S1B ). Figure 1E Fat is phosphorylated in S2 cells ( Figure 1F ). Closer analysis indicated that Fat 110 runs as a doublet in extracts from wildtype larvae ( Figure 1G ), suggesting that Fat is phosphorylated in vivo. Genetic studies indicate that the serine/threonine kinase Discs overgrown (Dco) functions in the Fat growth pathway [1] . A specific hypomorphic dco allele, dco 3 , which harbors two point mutations in the N-terminal domain, leads to massive tissue overgrowth, phenocopying Hpo pathway mutants [29] . dco 3 clones have elevated fj and Diap1 levels, indicative of increased Hpo pathway activity [1] . Interestingly, loss of dco results in reduced growth and decreased Diap1 levels, whereas overexpression of dco increases Diap1 protein levels [30] . Taken together, this suggests that Dco has both positive and negative roles in tissue growth during development [29] .
To assess whether Dco affects Fat phosphorylation in vivo, we isolated larval imaginal discs from dco 3 /dco i3-193 transheterozygotes and analyzed Fat electrophoretic mobility. Significantly, the Fat 110 doublet ran largely as a single band in dco mutants, which comigrated with the faster migrating band of the doublet ( Figure 1G ). These data suggest that Dco regulates the phosphorylation of Fat. To confirm that Dco can alter Fat electrophoretic mobility in vivo, we ubiquitously expressed a dominant-negative kinase-dead dco (Dco K38R ) UAS transgene [27] . Similar to dco 3 /dco i3-193 mutants, a single band at 110 kDa was detected from larval extract of dco K38R -expressing animals. Conversely, overexpression of wild-type dco decreased the mobility of coexpressed Fat 110 . Overexpression of dco K38R failed to induce similar alterations in Fat mobility, suggesting that the slower migrating form of the doublet represents a hyperphosphorylated form of Fat 110 ( Figure 1G ).
Dco/Casein Kinase I d/3 Can Bind and Phosphorylate Fat
The alteration of Fat electophoretic mobility in dco mutants suggested that Dco might bind and phosphorylate Fat. Consistent with this hypothesis, coexpression of Fat with Dco in Drosophila S2 cells increased the proportion of phosphatasesusceptible Fat 110 ( Figure 1F, lanes 3-4) . To examine whether Fat and Dco could interact, we expressed HA-tagged Dco and FLAG-tagged FatDECD. Coimmunoprecipitation experiments in both HEK293T and Drosophila S2 cells revealed that Dco binds strongly to the cytoplasmic domain of Fat ( Figures  2 and 3B) . The cytoplasmic domain of vertebrate Fat4 [28] can specifically bind CKI3 and CKId ( Figure S2B ), indicating that this interaction is conserved.
To define the Dco binding site, we generated a series of deletion mutants of Fat and examined their ability to coimmunoprecipitate Dco. Deletions removing up to 164 amino acids from the C terminus (CD164) had no effect on Fat-Dco binding. Further deletions weakened Dco binding. All detectable binding was lost when the last 203 residues were truncated from the C terminus of Fat (CD203; Figures 2A and 2B ). Internal deletions of 39 amino acids (D513-552) abolished Dco binding, whereas smaller deletions (D533-552) led to dramatically reduced binding ( Figure 2C ). Mutation of individual conserved residues within this region (AAGG or KAEG) had no detectable effect. These studies implicate a critical region for Dco binding that encompasses a 39 amino acid region, 164-203 residues from the C terminus.
To test whether Dco can phosphorylate the intracellular domain of Fat, we generated GST-fusion proteins and conducted in vitro phosphorylation assays. We incubated purified GST-Fat fragments with human CKI3 (86% identity, 92% similarity to Drosophila Dco). Consistent with multiple CKI consensus sites in the Fat cytoplasmic domain ( Figure S3 ), CKI3 phosphorylated Fat at multiple sites ( Figure 3A) . Proteomic analysis has identified five phosphorylated serines in the cytoplasmic domain of Fat in Drosophila embryos [31] , four of which conform to the CKI consensus. The finding that CKI3 can phosphorylate Fat at multiple sites in vitro is consistent with the large alteration in electrophoretic mobility of Fat seen in dco 3 mutants.
The dco 3 Mutation Does Not Impede Binding to the Fat Cytoplasmic Domain
The electrophoretic mobility of Fat 110 is altered in dco 3 mutants, so we speculated that the dco 3 mutation results in a loss of Fat binding. Unexpectedly, we found that recombinant Dco 3 bound strongly to the cytoplasmic domain of Fat in immunoprecipitation assays from Drosophila S2 and HEK293T cells ( Figure 3B and Figure S2A, respectively) . Thus, the alteration in Fat mobility seen in dco 3 mutants is not due to a loss of Fat binding. We speculate that the dco 3 mutation instead affects the ability of Dco to phosphorylate Fat and Fat-associated proteins.
These data suggest that loss of dco function, via the dco 3 mutation, leads to loss of Fat signaling. Clones of dco 3 exhibit increased expression of the well-characterized fat target gene fj [1] . To see whether this reflected loss of dco function, or a neomorphic effect of the dco 3 allele, we generated clones of dco i3-193 , a null allele for dco, and examined fj expression by using a fj-lacZ enhancer construct. Importantly, clones of dco i3-193 -and dco K38R -expressing clones both show strong upregulation of fj ( Figure S4 ), similar to loss of fat.
Posttranslational Modification of Fat 110 Is Altered in ds Mutants
To explore whether Fat phosphorylation was altered in PCP or growth pathway-regulating mutants, we examined extracts from wild-type, fat, fj, ex, sprouty, atrophin, and ds mutant discs ( Figure 4A ; Figure S5A) resolves largely as a single band in ds mutants ( Figure 4A ; Table S1 ). Ds binds Fat and recruits it to cell contacts. The alteration of Fat 110 mobility in ds mutants suggested that Fat is differentially phosphorylated when not bound by Ds.
How might binding by Ds alter the phosphorylation of Fat by Dco? In ds mutants, Fat becomes diffusely localized, suggesting that Ds raises the local concentration of Fat at cell contacts [25, 32, 33] . We speculated that Fat molecule cis-associations, promoted by Ds, might promote trans-phosphorylation by Dco. We performed coimmunoprecipitation experiments with FLAGtagged and HA-tagged Fat ( Figure 4B ; Figure S5B ). Significantly, we could coimmunoprecipitate HA-tagged Fat 110 (or FatICD; Figure S5B ) with FLAG-tagged FatDECD ( Figure 4B ). This indicates that Fat forms cis-dimers or oligomers, via the cytoplasmic region, and suggests a model whereby Fat activation involves receptor clustering. We propose that Ds binding increases the local concentration of Fat at cell contacts, favoring Fat cis-dimerization, thus promoting trans-phosphorylation of Fat by Dco.
Interestingly, borders of Ds expression promote Hippo activation [23] and uniform coexpression of fj and ds inhibits wing growth [22] [23] [24] . However, we find there is little, if any, alteration in the mobility of Fat when ds and fj are ubiquitously expressed ( Figure 4A ), nor when multiple clones are induced with ey-FLP (not shown). Thus, although ds is required for Fat phosphorylation, overexpression of ds is not sufficient to shift Fat 110 entirely to the hyperphosphorylated form. Loss of Ds leads to overgrowth and activation of the Hpo pathway, as does loss of Fat [34] , suggesting that Ds binding enhances the ability of Fat to suppress growth. Ds binding promotes Fat phosphorylation. Together these observations suggest that phosphorylated Fat is the active form in growth repression. This is consistent with our observation that alleles of dco that promote growth show reduced Fat phosphorylation. We suggest that Dco phosphorylates Fat. Dco may also phosphorylate other proteins recruited by Fat, modifying their activity in PCP or growth signaling. Significantly, Dco regulates not only growth but also PCP [26, 27] . Fat has been proposed to recruit Expanded to control Hpo pathway activation, but not PCP [2] [3] [4] 35] . Conversely, Atrophin binds to the Fat cytoplasmic domain, functioning with Fat to regulate PCP but not growth [36] . Phosphorylation of Expanded and/or Atrophin by Dco may provide a mechanism by which Dco and Fat can regulate growth and PCP.
By demonstrating that Dco binds and phosphorylates Fat, we have provided the first direct biochemical link between Fat and downstream components of the Hpo growth control pathway. Genetic studies indicate that fat regulatin of Hpo pathway activity is likely to be complicated and dependent on multiple players and pathways [37] [38] [39] [40] [41] . Understanding how Fat coordinately regulates growth and planar polarity will require an understanding of the full complement of proteins that bind to Fat and exploration of how Ds-and Dco-dependent phosphorylation affects the activity of Fat in these diverse pathways. 
